Neutrophil myeloperoxidase as a functional biomarker for RSV severity: implications for in vitro therapeutic screening.
Machaela Palor, Tereza Masonou, Elisabeth J. Robinson…·Claire Mary Smith
This study identifies neutrophil myeloperoxidase (MPO) as a biomarker for RSV severity and demonstrates its utility as a functional readout for evaluating antiviral therapies in an in vitro model.